Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here we describe two non-invasive methods to chronically control neuronal activity using chemogenetics in mice. Eye-drops were used to deliver clozapine-N-oxide (CNO) daily. We also describe two methods for prolonged administration of CNO in drinking water. These strategies for chronic neuronal control require minimal intervention reducing animals’ stress.

Abstract

Chemogenetic strategies have emerged as reliable tools for remote control of neuronal activity. Among these, designer receptors exclusively activated by designer drugs (DREADDs) have become the most popular chemogenetic approach used in modern neuroscience. Most studies deliver the ligand clozapine-N-oxide (CNO) using a single intraperitoneal injection, which is suitable for the acute activation/inhibition of the targeted neuronal population. There are, however, only a few examples of strategies for chronic modulation of DREADD-controlled neurons, the majority of which rely on the use of delivery systems that require surgical intervention. Here, we expand on two non-invasive strategies for delivering the ligand CNO to chronically manipulate neural population in mice. CNO was administered either by using repetitive (daily) eye-drops, or chronically through the animal's drinking water. These non-invasive paradigms result in robust activation of the designer receptors that persisted throughout the CNO treatments. The methods described here offer alternatives for the chronic DREADD-mediated control of neuronal activity and may be useful for experiments designed to evaluate behavior in freely moving animals, focusing on less-invasive CNO delivery methods.

Introduction

Technical advances in the field of neuroscience have allowed scientists to precisely identify and control the activity of particular neuronal populations1. This has contributed to better understand the basis of neuronal circuits and their impact on animal behavior, as well as, revising established dogmas2,3. Among these novel tools, optogenetic and chemogenetic strategies have had a profound impact not only on the quality of discoveries but also on the way experiments are conceived and designed4. In the present manuscript, we focus on chemogenetic strategies for ....

Protocol

All animals were handled in accordance with guidelines of the Animal Care and Use Committees of the National Institute of Mental Health (NIMH). All efforts were made to minimize the pain and the number of animals used.

1. Adeno-associated virus injections in the hippocampus

NOTE: Wild type male mice of mixed background (B6/129 F1 hybrid, 3 months old) were for stereotaxically injected with an AAV encoding the M3 muscarinic receptor (hM3Dq) into t.......

Representative Results

We observed that repetitive CNO delivery using eye-drops elicited a robust induction of c-Fos expression in most infected neurons (Figure 1C), showing that the effectiveness of CNO delivery is sustained during the repetitive exposure. Furthermore, a significant induction of c-Fos was observed in samples collected 2 h after CNO treatment, compared to samples obtained 6 h after CNO exposure (Figures 1D-E), demonstrating that changes induced by CNO are time-dependent.

Discussion

DREADDs have emerged as a popular and effective approach to remotely manipulate neuronal activity17. The design of alternative strategies for CNO delivery will broadly increase the spectrum of options available for specific experimental settings. In addition, non-invasive strategies for the delivery of CNO minimize any potential misinterpretation of results by reducing adverse side effects that can directly impact the animal’s health. Here, we described two non-invasive strategies for CNO de.......

Acknowledgements

This work was supported by the intramural research program at the National Institute of Mental Health (ZIA MH002964-02). We would like to thank the support of the NIMH IRP Rodent Behavioral Core (ZIC MH002952).

....

Materials

NameCompanyCatalog NumberComments
BSASigma life science#A2153-100GLyophilized powder ≥96% (agarose gel electrophoresis)
C57BL/6J miceThe Jackson laboratory#000664male mice, 3 months old
CapillariesDrummond Scientific Company#3-000-203-G/XOuter diameter: 1.14 in.
Clozapine-N-oxideSigma#C08325mg
ForaneBaxter#NDC 10019-360-60Isoflurane, USP
Microinjector IIIDrummond Scientific Company#3-000-207Nanoject III - Programmable Nanoliter Injector
Mounting mediaInvitrogen#P36930Prolong Gold antifade reagent
ParaformaldehydeElectron Microscopy Sciences#1571016% aqueous solution (methanol free), 10 ml
Primary c-Fos AntibodyCell signaling technology#2250Sc-Fos (9F6) Rabbit mAb (100µl)
rAAV5/hSyn-hm3D-mCherryUNC Vector CoreTiter: ~3x10e12 vg/mL
rAAV5/hSyn-mCherryUNC Vector CoreTiter: ~3x10e12 vg/mL
Secondary AntibodyInvitrogen#A21206Alexa Fluor TM 488 Donkey anti-rabbit IgG(H+L), 2mg/ml
Triton X-100americanbio.com#AB02025-00100

References

  1. Park, H. G., Carmel, J. B. Selective Manipulation of Neural Circuits. Neurotherapeutics. 13 (2), 311-324 (2016).
  2. Muir, J., Lopez, J., Bagot, R. C. Wiring the depressed brain: optogenetic and chemogenet....

Explore More Articles

DREADDChemogeneticsCNONon invasiveChronicRepetitiveEyedropDrinking WaterStereotaxic SurgeryHippocampusAAVAnalgesiaHandlingAcclimationDosage

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved